Securities Law News

Ex-PetMed Exec Settles SEC Insider Trading Allegations

Sept. 24, 2019, 5:49 PM

A former PetMed Express Inc. executive will pay almost $515,000 to end an SEC suit accusing him of using insider trading, according to Sept. 24 filings in Florida federal court.

James Alex Irvin was the marketing director at the online pet pharmacy, also known as 1-800-PetMeds, when he traded ahead of six PetMed quarterly earnings announcements, the Securities and Exchange Commission said in the U.S. District Court for the Southern District of Florida.

Irvin, who also served on PetMed’s management committee, “realized profits and avoided losses of $227,795,” the SEC said. An unnamed college friend Irvin tipped to trade PetMed...

To read the full article log in. To learn more about a subscription click here.